Advocates

This fact sheet provides a general overview of the Minority AIDS Initiative (MAI) and the Minority HIV/AIDS Fund, emphasizing the need to reaffirm our commitment to the MAI, including increasing funding and transparency.

Although hepatitis B is preventable and treatable, there is still no cure for this disease. In addition to the devastating toll on patients and their families, ignoring hepatitis B costs the U.S. an estimated $4 billion per year in medical costs. Yet, the NIH will spend only $66 million in FY 2021 on hepatitis B research. Read more in this fact sheet.